Rautio J - Search Results

1

Specific transport of temozolomide does not override DNA repair-mediated chemoresistance.

Bahrami K, Kärkkäinen J, Bibi S, Huttunen J, Tampio J, Montaser AB, Moody CL, Lehtonen M, Rautio J, Wheelhouse RT, Huttunen KM. Bahrami K, et al. Among authors: rautio j. Eur J Pharm Sci. 2024 Apr 1;195:106661. doi: 10.1016/j.ejps.2023.106661. Epub 2023 Dec 3. Eur J Pharm Sci. 2024. PMID: 38052257 Free article.

2

[Prodrug technology in the development of medicinal agents].

Peura L, Malmioja K, Rautio J. Peura L, et al. Among authors: rautio j. Duodecim. 2011;127(3):263-72. Duodecim. 2011. PMID: 21438349 Review. Finnish.

3

Midazolam exhibits characteristics of a highly permeable P-glycoprotein substrate.

Tolle-Sander S, Rautio J, Wring S, Polli JW, Polli JE. Tolle-Sander S, et al. Among authors: rautio j. Pharm Res. 2003 May;20(5):757-64. doi: 10.1023/a:1023433502647. Pharm Res. 2003. PMID: 12751631

4

In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates.

Rautio J, Humphreys JE, Webster LO, Balakrishnan A, Keogh JP, Kunta JR, Serabjit-Singh CJ, Polli JW. Rautio J, et al. Drug Metab Dispos. 2006 May;34(5):786-92. doi: 10.1124/dmd.105.008615. Epub 2006 Feb 2. Drug Metab Dispos. 2006. PMID: 16455806

5

[Prodrugs].

Järvinen T, Rautio J, Niemi R. Järvinen T, et al. Among authors: rautio j. Duodecim. 1997;113(24):2564-8. Duodecim. 1997. PMID: 10892164 Finnish. No abstract available.

6

Aminocarbonyloxymethyl ester prodrugs of flufenamic acid and diclofenac: suppressing the rearrangement pathway in aqueous media.

Ribeiro L, Silva N, Iley J, Rautio J, Järvinen T, Mota-Filipe H, Moreira R, Mendes E. Ribeiro L, et al. Among authors: rautio j. Arch Pharm (Weinheim). 2007 Jan;340(1):32-40. doi: 10.1002/ardp.200600145. Arch Pharm (Weinheim). 2007. PMID: 17206608

7

LAT1-mediated prodrug uptake: a way to breach the blood-brain barrier?

Rautio J, Gynther M, Laine K. Rautio J, et al. Ther Deliv. 2013 Mar;4(3):281-4. doi: 10.4155/tde.12.165. Ther Deliv. 2013. PMID: 23442072 No abstract available.

8

Inefficient central nervous system delivery limits the use of ibuprofen in neurodegenerative diseases.

Mannila A, Rautio J, Lehtonen M, Järvinen T, Savolainen J. Mannila A, et al. Among authors: rautio j. Eur J Pharm Sci. 2005 Jan;24(1):101-5. doi: 10.1016/j.ejps.2004.10.004. Eur J Pharm Sci. 2005. PMID: 15626583

9

Plasma and cerebrospinal fluid concentrations of indomethacin in children after intravenous administration.

Mannila A, Kumpulainen E, Lehtonen M, Heikkinen M, Laisalmi M, Salo T, Rautio J, Savolainen J, Kokki H. Mannila A, et al. Among authors: rautio j. J Clin Pharmacol. 2007 Jan;47(1):94-100. doi: 10.1177/0091270006295202. J Clin Pharmacol. 2007. PMID: 17192507 Clinical Trial.

10

Novel cyclic phosphate prodrug approach for cytochrome P450-activated drugs containing an alcohol functionality.

Huttunen KM, Mähönen N, Leppänen J, Vepsäläinen J, Juvonen RO, Raunio H, Kumpulainen H, Järvinen T, Rautio J. Huttunen KM, et al. Among authors: rautio j. Pharm Res. 2007 Apr;24(4):679-87. doi: 10.1007/s11095-006-9187-y. Epub 2007 Feb 15. Pharm Res. 2007. PMID: 17372695

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters